Pregnancy, High Risk
68
15
20
28
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.9%
2 terminated out of 68 trials
93.3%
+6.8% vs benchmark
10%
7 trials in Phase 3/4
14%
4 of 28 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 28 completed trials
Clinical Trials (68)
NOURISH - A Healthcare-community Partnership to Improve Nutrition for Optimal Glycemic Control and Pregnancy Outcomes With Pregestational Diabetes
Permissive Versus Strict Intrapartum Glucose Management in Type 1 Diabetes (PRISM-T1D)
MOCHA: Embedded Inpatient Mental Health Care for High-Risk Perinatal Patients
Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women
Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes
Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes
Psychobiological Interventions in Pregnancy
A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE
Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)
Continuous Glucose Monitoring (CGM) Substudy of the DECIDE RCT
Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE)
Relationship of DV Doppler Parameters to Perinatal Outcomes in IUGR vs Non-IUGR
Continuous Glucose Monitor Use in Pregnancy
Nurse Family Partnership for Women With Previous Live Births
Early Detection of Gestational Diabetes Mellitus in Pregnancy
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy
Patient Versus Provider-led Titration of Insulin for Glycemic Control in Gestational Diabetes (EMPOWER)